The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
A Blueprint for HIV Vaccine Discovery
Open accessAbstract
Despite numerous attempts over many years to develop an HIV vaccine based on classical strategies, none has convincingly succeeded to date. A number of approaches are being pursued in the field, including building upon possible efficacy indicated by the recent RV144 clinical trial, which combined two HIV vaccines. Here, we argue for an approach based, in part, on understanding the HIV envelope spike and its interaction with broadly neutralizing antibodies (bnAbs) at the molecular level and using this understanding to design immunogens as possible vaccines. BnAbs can protect against virus challenge in animal models and many such antibodies have been isolated recently. We further propose that studies focused on how best to provide T cell help to B cells that produce bnAbs are crucial for optimal immunization strategies. The synthesis of rational immunogen design and immunization strategies, together with iterative improvements, offers great promise for advancing toward an HIV vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
Self-citationHeterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationBroad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Self-citationJohnston, R. J., Poholek, A. C., DiToro, D., Yusuf, I., Eto, D., Barnett, B., Dent, A. L., Craft, J., & Crotty, S. (2009) · Science · doi:10.1126/science.1175870 · Cited by 1,626
Self-citationThe HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
Self-citationBcl6 mediates the development of T follicular helper cells
Nurieva, R. I., Chung, Y., Martinez, G. J., Yang, X. O., Tanaka, S., Matskevitch, T. D., Wang, Y.-H., & Dong, C. (2009) · Science · doi:10.1126/science.1176676 · Cited by 1,506
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Self-citationVictora, G. D., Schwickert, T. A., Fooksman, D. R., Kamphorst, A. O., Meyer-Hermann, M., Dustin, M. L., & Nussenzweig, M. C. (2010) · Cell · doi:10.1016/j.cell.2010.10.032 · Cited by 1,238
Self-citationThe Transcriptional Repressor Bcl-6 Directs T Follicular Helper Cell Lineage Commitment
Yu, D., Rao, S., Tsai, L. M., Lee, S. K., He, Y., Sutcliffe, E. L., Srivastava, M., Linterman, M., Zheng, L., Simpson, N., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.07.002 · Cited by 1,228
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Self-citationStructural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Self-citationSystems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
Self-citationTiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,107
Self-citationLi, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Hansen, S. G., Ford, J. C., Lewis, M. S., Ventura, A. B., Hughes, C. M., Coyne-Johnson, L., Whizin, N., Oswald, K., Shoemaker, R., Swanson, T., et al. (2011) · Nature · doi:10.1038/nature10003 · Cited by 988
Choi, Y. S., Kageyama, R., Eto, D., Escobar, T. C., Johnston, R. J., Monticelli, L., Lao, C., & Crotty, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.023 · Cited by 958
Self-citationThe rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., et al. (2009) · Nature · doi:10.1038/nature07930 · Cited by 867
Self-citationPitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J. W., Choopanya, K., & Bangkok Vaccine Evaluation Group (2006) · The Journal of Infectious Diseases · doi:10.1086/508748 · Cited by 847
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Huang, J., Ofek, G., Laub, L., Louder, M. K., Doria-Rose, N. A., Longo, N. S., Imamichi, H., Bailer, R. T., Chakrabarti, B., Sharma, S. K., et al. (2012) · Nature · doi:10.1038/nature11544 · Cited by 828
Self-citationMolecular architecture of native HIV-1 gp120 trimers
Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G., & Subramaniam, S. (2008) · Nature · doi:10.1038/nature07159 · Cited by 816
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Self-citationFocused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Wu, X., Zhou, T., Zhu, J., Zhang, B., Georgiev, I., Wang, C., Chen, X., Longo, N. S., Louder, M., McKee, K., et al. (2011) · Science · doi:10.1126/science.1207532 · Cited by 784
Self-citationAntibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Self-citationStructural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Self-citationCardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Self-citationAntibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
Self-citationMeasles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 608
Simek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
Self-citationTargeting early infection to prevent HIV-1 mucosal transmission
Haase, A. T. (2010) · Nature · doi:10.1038/nature08757 · Cited by 593
Sather, D. N., Armann, J., Ching, L. K., Mavrantoni, A., Sellhorn, G., Caldwell, Z., Yu, X., Wood, B., Self, S., Kalams, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02036-08 · Cited by 528
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
Gray, E. S., Madiga, M. C., Hermanus, T., Moore, P. L., Wibmer, C. K., Tumba, N. L., Werner, L., Mlisana, K., Sibeko, S., Williamson, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00198-11 · Cited by 466
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Barouch, D. H., Liu, J., Li, H., Maxfield, L. F., Abbink, P., Lynch, D. M., Iampietro, M. J., SanMiguel, A., Seaman, M. S., Ferrari, G., et al. (2012) · Nature · doi:10.1038/nature10766 · Cited by 465
Self-citationRoben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., & Burton, D. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 455
Self-citationImmune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Liu, J., O’Brien, K. L., Lynch, D. M., Simmons, N. L., La Porte, A., Riggs, A. M., Abbink, P., Coffey, R. T., Grandpre, L. E., Seaman, M. S., et al. (2009) · Nature · doi:10.1038/nature07469 · Cited by 452
Self-citationGP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Self-citationConduits Mediate Transport of Low-Molecular-Weight Antigen to Lymph Node Follicles
Roozendaal, R., Mempel, T. R., Pitcher, L. A., Gonzalez, S. F., Verschoor, A., Mebius, R. E., von Andrian, U. H., & Carroll, M. C. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.014 · Cited by 444
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Stamatatos, L., Morris, L., Burton, D. R., & Mascola, J. R. (2009) · Nature Medicine · doi:10.1038/nm.1949 · Cited by 430
Self-citationCorti, D., Langedijk, J. P. M., Hinz, A., Seaman, M. S., Vanzetta, F., Fernandez-Rodriguez, B. M., Silacci, C., Pinna, D., Jarrossay, D., Balla-Jhagjhoorsingh, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008805 · Cited by 426
Salzwedel, K., West, J. T., & Hunter, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2469-2480.1999 · Cited by 422
Expansion of HIV-specific T follicular helper cells in chronic HIV infection
Lindqvist, M., van Lunzen, J., Soghoian, D. Z., Kuhl, B. D., Ranasinghe, S., Kranias, G., Flanders, M. D., Cutler, S., Yudanin, N., Muller, M. I., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64314 · Cited by 418
Self-citationBurton, D. R., Poignard, P., Stanfield, R. L., & Wilson, I. A. (2012) · Science · doi:10.1126/science.1225416 · Cited by 415
Self-citationThe Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
Li, Y., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X., Shaw, G. M., Connors, M., Wyatt, R. T., et al. (2007) · Nature Medicine · doi:10.1038/nm1624 · Cited by 383
Self-citationIncreasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Diskin, R., Scheid, J. F., Marcovecchio, P. M., West, A. P., Klein, F., Gao, H., Gnanapragasam, P. N. P., Abadir, A., Seaman, M. S., Nussenzweig, M. C., et al. (2011) · Science · doi:10.1126/science.1213782 · Cited by 375
Self-citationWalker, L. M., Simek, M. D., Priddy, F., Gach, J. S., Wagner, D., Zwick, M. B., Phogat, S. K., Poignard, P., & Burton, D. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001028 · Cited by 370
Self-citationBinley, J. M., Lybarger, E. A., Crooks, E. T., Seaman, M. S., Gray, E., Davis, K. L., Decker, J. M., Wycuff, D., Harris, L., Hawkins, N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01762-08 · Cited by 355
Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1
Moore, P. L., Crooks, E. T., Porter, L., Zhu, P., Cayanan, C. S., Grise, H., Corcoran, P., Zwick, M. B., Franti, M., Morris, L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2515-2528.2006 · Cited by 343
Self-citationB cell follicles and antigen encounters of the third kind
Cyster, J. G. (2010) · Nature Immunology · doi:10.1038/ni.1946 · Cited by 339
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Karlsson Hedestam, G. B., Fouchier, R. A. M., Phogat, S., Burton, D. R., Sodroski, J., & Wyatt, R. T. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1819 · Cited by 339
Self-citationWalker, B. D., & Burton, D. R. (2008) · Science · doi:10.1126/science.1152622 · Cited by 338
Self-citationDoria-Rose, N. A., Klein, R. M., Daniels, M. G., O'Dell, S., Nason, M., Lapedes, A., Bhattacharya, T., Migueles, S. A., Wyatt, R. T., Korber, B. T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01482-09 · Cited by 336
Self-citationSattentau, Q. J., & Moore, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.185 · Cited by 334
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
Doores, K. J., Bonomelli, C., Harvey, D. J., Vasiljevic, S., Dwek, R. A., Burton, D. R., Crispin, M., & Scanlan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006498107 · Cited by 329
Self-citationEarly Events in Sexual Transmission of HIV and SIV and Opportunities for Interventions
Haase, A. T. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-080709-124959 · Cited by 321
CD4 T follicular helper cell dynamics during SIV infection
Petrovas, C., Yamamoto, T., Gerner, M. Y., Boswell, K. L., Wloka, K., Smith, E. C., Ambrozak, D. R., Sandler, N. G., Timmer, K. J., Sun, X., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63039 · Cited by 317
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Mikell, I., Sather, D. N., Kalams, S. A., Altfeld, M., Alter, G., & Stamatatos, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001251 · Cited by 315
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Chen, L., Do Kwon, Y., Zhou, T., Wu, X., O’Dell, S., Cavacini, L., Hessell, A. J., Pancera, M., Tang, M., Xu, L., et al. (2009) · Science · doi:10.1126/science.1175868 · Cited by 300
Self-citationAntibody vs. HIV in a clash of evolutionary titans
Burton, D. R., Stanfield, R. L., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505126102 · Cited by 299
Self-citationBrainard, D. M., Seung, E., Frahm, N., Cariappa, A., Bailey, C. C., Hart, W. K., Shin, H.-S., Brooks, S. F., Knight, H. L., Eichbaum, Q., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02207-08 · Cited by 288
Self-citationCrystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions
Buzon, V., Natrajan, G., Schibli, D., Campelo, F., Kozlov, M. M., & Weissenhorn, W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000880 · Cited by 285
HIV-Specific Cytolytic CD4 T Cell Responses During Acute HIV Infection Predict Disease Outcome
Soghoian, D. Z., Jessen, H., Flanders, M., Sierra-Davidson, K., Cutler, S., Pertel, T., Ranasinghe, S., Lindqvist, M., Davis, I., Lane, K., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003165 · Cited by 279
Self-citationElicitation of structure-specific antibodies by epitope scaffolds
Ofek, G., Guenaga, F. J., Schief, W. R., Skinner, J., Baker, D., Wyatt, R., & Kwong, P. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004728107 · Cited by 278
Self-citationInduction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
McElrath, M. J., & Haynes, B. F. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.011 · Cited by 270
Self-citationContributions of humoral and cellular immunity to vaccine-induced protection in humans
Amanna, I. J., & Slifka, M. K. (2011) · Virology · doi:10.1016/j.virol.2010.12.016 · Cited by 263
The antiviral activity of antibodies in vitro and in vivo
Parren, P. W. H. I., & Burton, D. R. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)77018-6 · Cited by 261
Self-citationXiao, X., Chen, W., Feng, Y., Zhu, Z., Prabakaran, P., Wang, Y., Zhang, M.-Y., Longo, N. S., & Dimitrov, D. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.029 · Cited by 260
Li, Y., Svehla, K., Louder, M. K., Wycuff, D., Phogat, S., Tang, M., Migueles, S. A., Wu, X., Phogat, A., Shaw, G. M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01992-08 · Cited by 259
Self-citationAn HIV Vaccine — Evolving Concepts
Johnston, M. I., & Fauci, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra066267 · Cited by 257 · cited 1×
“We note that such a vaccine may well also need to induce HIV-specific CD8+ T cell responses for maximal efficacy as considered elsewhere (Barouch and Korber, 2010; Johnston and Fauci, 2007; McElrath and Haynes, 2010; Walker and Burton, 2008; Watkins, 2008).”
West, A. P., Diskin, R., Nussenzweig, M. C., & Bjorkman, P. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208984109 · Cited by 231
Self-citationBonomelli, C., Doores, K. J., Dunlop, D. C., Thaney, V., Dwek, R. A., Burton, D. R., Crispin, M., & Scanlan, C. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023521 · Cited by 230
Self-citationGoenka, R., Barnett, L. G., Silver, J. S., O’Neill, P. J., Hunter, C. A., Cancro, M. P., & Laufer, T. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100853 · Cited by 229
Rolf, J., Bell, S. E., Kovesdi, D., Janas, M. L., Soond, D. R., Webb, L. M. C., Santinelli, S., Saunders, T., Hebeis, B., Killeen, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001730 · Cited by 227
Wheeler, L. A., Trifonova, R., Vrbanac, V., Basar, E., McKernan, S., Xu, Z., Seung, E., Deruaz, M., Dudek, T., Einarsson, J. I., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45876 · Cited by 227
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
Azoitei, M. L., Correia, B. E., Ban, Y.-E. A., Carrico, C., Kalyuzhniy, O., Chen, L., Schroeter, A., Huang, P.-S., McLellan, J. S., Kwong, P. D., et al. (2011) · Science · doi:10.1126/science.1209368 · Cited by 224
Self-citationMass Spectrometric Characterization of the Glycosylation Pattern of HIV-gp120 Expressed in CHO Cells
Zhu, X., Borchers, C., Bienstock, R. J., & Tomer, K. B. (2000) · Biochemistry · doi:10.1021/bi000432m · Cited by 222
Correia, B. E., Ban, Y.-E. A., Holmes, M. A., Xu, H., Ellingson, K., Kraft, Z., Carrico, C., Boni, E., Sather, D. N., Zenobia, C., et al. (2010) · Structure · doi:10.1016/j.str.2010.06.010 · Cited by 218
Self-citationRational antibody-based HIV-1 vaccine design: current approaches and future directions
Walker, L. M., & Burton, D. R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.02.012 · Cited by 210
Self-citationHumanized Mice for Modeling Human Infectious Disease: Challenges, Progress, and Outlook
Legrand, N., Ploss, A., Balling, R., Becker, P. D., Borsotti, C., Brezillon, N., Debarry, J., de Jong, Y., Deng, H., Di Santo, J. P., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.06.006 · Cited by 207
Mizuochi, T., Spellman, M. W., Larkin, M., Solomon, J., Basa, L. J., & Feizi, T. (1988) · Biochemical Journal · doi:10.1042/bj2540599 · Cited by 201
Poignard, P., Moulard, M., Golez, E., Vivona, V., Franti, M., Venturini, S., Wang, M., Parren, P. W. H. I., & Burton, D. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.353-365.2003 · Cited by 188
Self-citationCoordinate linkage of HIV evolution reveals regions of immunological vulnerability
Dahirel, V., Shekhar, K., Pereyra, F., Miura, T., Artyomov, M., Talsania, S., Allen, T. M., Altfeld, M., Carrington, M., Irvine, D. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105315108 · Cited by 184
Self-citationGray, E. S., Taylor, N., Wycuff, D., Moore, P. L., Tomaras, G. D., Wibmer, C. K., Puren, A., DeCamp, A., Gilbert, P. B., Wood, B., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00758-09 · Cited by 183
The Antibody Response against HIV-1
Overbaugh, J., & Morris, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007039 · Cited by 177
In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
Day, P. M., Kines, R. C., Thompson, C. D., Jagu, S., Roden, R. B., Lowy, D. R., & Schiller, J. T. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.003 · Cited by 171
Sette, A., Moutaftsi, M., Moyron-Quiroz, J., McCausland, M. M., Davies, D. H., Johnston, R. J., Peters, B., Rafii-El-Idrissi Benhnia, M., Hoffmann, J., Su, H.-P., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.018 · Cited by 168
Self-citationAntibody polyspecificity and neutralization of HIV-1: A hypothesis
Haynes, B. F., Moody, M. A., Verkoczy, L., Kelsoe, G., & Alam, S. M. (2006) · Human Antibodies · doi:10.3233/hab-2005-143-402 · Cited by 163
Efficient differentiation and function of human macrophages in humanized CSF-1 mice
Rathinam, C., Poueymirou, W. T., Rojas, J., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Rongvaux, A., Eynon, E. E., Manz, M. G., & Flavell, R. A. (2011) · Blood · doi:10.1182/blood-2010-12-326926 · Cited by 161
Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer
Mao, Y., Wang, L., Gu, C., Herschhorn, A., Xiang, S.-H., Haim, H., Yang, X., & Sodroski, J. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2351 · Cited by 160
Li, Y., Svehla, K., Mathy, N. L., Voss, G., Mascola, J. R., & Wyatt, R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1414-1426.2006 · Cited by 159
Self-citationKlein, F., Gaebler, C., Mouquet, H., Sather, D. N., Lehmann, C., Scheid, J. F., Kraft, Z., Liu, Y., Pietzsch, J., Hurley, A., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120423 · Cited by 159
Self-citationRational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1
Kwong, P. D., Mascola, J. R., & Nabel, G. J. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007278 · Cited by 159
Moore, P. L., Gray, E. S., Sheward, D., Madiga, M., Ranchobe, N., Lai, Z., Honnen, W. J., Nonyane, M., Tumba, N., Hermanus, T., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02658-10 · Cited by 159
Hong, J. J., Amancha, P. K., Rogers, K. A., Ansari, A. A., & Villinger, F. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103138 · Cited by 158
Trafficking of B Cell Antigen in Lymph Nodes
González, S., Degn, S. E., Pitcher, L. A., Woodruff, M. C., Heesters, B. A., & Carroll, M. C. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101255 · Cited by 146
Raška, M., Takahashi, K., Czerneková, L., Zachová, K., Hall, S. D., Moldoveanu, Z., Elliott, M. C., Wilson, L. S., Brown, R., Jancova, D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085472 · Cited by 144
Go, E. P., Irungu, J. W., Zhang, Y., Dalpathado, D. S., Liao, H., Sutherland, L. L., Alam, S. M., Haynes, B. F., & Desaire, H. (2008) · Journal of Proteome Research · doi:10.1021/pr7006957 · Cited by 135
Crooks, E. T., Moore, P. L., Franti, M., Cayanan, C. S., Zhu, P., Jiang, P., de Vries, R. P., Wiley, C. L., Zharkikh, I. L., Schülke, N., et al. (2007) · Virology · doi:10.1016/j.virol.2007.04.033 · Cited by 132
Self-citationHIV-1 and influenza antibodies: seeing antigens in new ways
Kwong, P. D., & Wilson, I. A. (2009) · Nature Immunology · doi:10.1038/ni.1746 · Cited by 130
Self-citationFalkowska, E., Ramos, A. G., Feng, Y., Zhou, T., Moquin, S. A., Walker, L. M., Wu, X., Seaman, M. S., Wrin, T., Kwong, P. D., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06973-11 · Cited by 122
Self-citationChallenges for structure-based HIV vaccine design
Schief, W. R., Ban, Y. A., & Stamatatos, L. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832e6184 · Cited by 120
Self-citationHIV-1 Vaccine Development After STEP
Barouch, D. H., & Korber, B. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.042508.093728 · Cited by 119
Self-citationGo, E. P., Hewawasam, G. S., Liao, H., Chen, H., Ping, L., Anderson, J. A., Hua, D., Haynes, B. F., & Desaire, H. (2011) · Journal of Virology · doi:10.1128/jvi.05053-11 · Cited by 118
West, A. P., Diskin, R., Nussenzweig, M. C., & Björkman, P. J. (2012) · Retrovirology · doi:10.1186/1742-4690-9-s2-o33 · Cited by 114
Self-citationCrooks, E. T., Tong, T., Osawa, K., & Binley, J. Μ. (2011) · Journal of Virology · doi:10.1128/jvi.00154-11 · Cited by 106
McLellan, J. S., Correia, B. E., Chen, M., Yang, Y., Graham, B. S., Schief, W. R., & Kwong, P. D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.044 · Cited by 105
Self-citationKulkarni, A. B., Collins, P. L., Bacik, I., Yewdell, J. W., Bennink, J. R., Crowe, J. E., & Murphy, B. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1261-1264.1995 · Cited by 102
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies
Verkoczy, L. K., Kelsoe, G. H., Moody, M. A., & Haynes, B. F. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.04.003 · Cited by 100
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection
Smith, D. M., Strain, M. C., Frost, S. D. W., et al. (2006) · Virology · doi:10.1016/j.virol.2006.08.009 · Cited by 99
Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins
Go, E. P., Chang, Q., Liao, H., Sutherland, L. L., Alam, S. M., Haynes, B. F., & Desaire, H. (2009) · Journal of Proteome Research · doi:10.1021/pr9002728 · Cited by 95
CD4 + T cells support cytotoxic T lymphocyte priming by controlling lymph node input
Kumamoto, Y., Mattei, L. M., Sellers, S., Payne, G. W., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100567108 · Cited by 95
Breden, F. J., Lepik, C., Longo, N. S., Montero, M., Lipsky, P. E., & Scott, J. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016857 · Cited by 90
Walker, L. M., Sok, D., Nishimura, Y., Donau, O. K., Sadjadpour, R., Gautam, R., Shingai, M., Pejchal, R., Ramos, A. G., Simek, M. D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117531108 · Cited by 84
Self-citationInnate Immune Sensing of HIV-1 by Dendritic Cells
Luban, J. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.002 · Cited by 82
Immunogenicity of HIV-1 envelope glycoprotein oligomers
Forsell, M. N. E., Schief, W. R., & Wyatt, R. T. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832edc19 · Cited by 79
Self-citationEggink, D., Melchers, M., Wuhrer, M., van Montfort, T., Dey, A., Naaijkens, B. A., David, K. B., Douce, V. L., Deelder, A. M., Kang, K., et al. (2010) · Virology · doi:10.1016/j.virol.2010.02.019 · Cited by 77
Klavinskis, L. S., Geckeler, R., & Oldstone, M. B. A. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-12-3317 · Cited by 70
Correia, B. E., Ban, Y. A., Friend, D. J., Ellingson, K., Xu, H., Boni, E., Bradley-Hewitt, T., Bruhn-Johannsen, J. F., Stamatatos, L., Strong, R. K., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.09.061 · Cited by 62
Self-citationKang, Y., Andjelić, S., Binley, J. Μ., Crooks, E. T., Franti, M., Iyer, S. P. N., Donovan, G. P., Dey, A., Zhu, P., Roux, K. H., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.037 · Cited by 60
Journal of AIDS & Clinical Research
Kong, L., & Sattentau, Q. J. (2019) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113 · Cited by 59
The changing face of HIV vaccine research
Kwong, P. D., Mascola, J. R., & Nabel, G. J. (2012) · Journal of the International AIDS Society · doi:10.7448/ias.15.2.17407 · Cited by 58
Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1
Scarlatti, G., Leitner, T., Hodara, V. L., Halapi, E. C., Rossi, P., Albert, J., & Fenyõ, É. M. (1993) · AIDS · doi:10.1097/00002030-199311002-00010 · Cited by 57
Hammonds, J. E., Chen, X., FOUTS, T. R., DeVico, A. L., Montefiori, D. C., & Spearman, P. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14804-14814.2005 · Cited by 52
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo
Banerjee, K., Andjelić, S., Klasse, P. J., Kang, Y., Sanders, R. W., Michael, E., Durso, R. J., Ketas, T. J., Olson, W. C., & Moore, J. P. (2009) · Virology · doi:10.1016/j.virol.2009.04.001 · Cited by 48
Kuate, S., Stahl‐Hennig, C., Stoiber, H., Nchinda, G., Floto, A., Franz, M., Sauermann, U., Bredl, S., Deml, L., Ignatius, R., et al. (2006) · Virology · doi:10.1016/j.virol.2006.03.009 · Cited by 46
Prospects for an HIV vaccine: leading B cells down the right path
Moir, S. L., Malaspina, A., & Fauci, A. S. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2194 · Cited by 44
Marsac, D., Loirat, D., Petit, C., Schwartz, O., & Michel, M.-L. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7544-7553.2002 · Cited by 39
Crotty, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01117.x · Cited by 38
Self-citationBanerjee, K., Michael, E., Eggink, D., van Montfort, T., Lasnik, A. B., Palmer, K. E., Sanders, R. W., Moore, J. P., & Klasse, P. J. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0101 · Cited by 32
Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design
Kong, L., & Sattentau, Q. J. (2012) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.s8-003 · Cited by 28
Cited by
Germinal Center B Cell Dynamics
Mesin, L., Ersching, J., & Victora, G. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.001 · Cited by 994
Locci, M., Havenar-Daughton, C., Landais, E., Wu, J., Kroenke, M. A., Arlehamn, C. L., Su, L. F., Cubas, R., Davis, M. M., Sette, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.031 · Cited by 868
Self-citationRational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770
Self-citationDevelopmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Doria-Rose, N. A., Schramm, C. A., Gorman, J., Moore, P. L., Bhiman, J. N., DeKosky, B. J., Ernandes, M. J., Georgiev, I. S., Kim, H. J., Pancera, M., et al. (2014) · Nature · doi:10.1038/nature13036 · Cited by 709
Self-citationThe promise and challenge of high-throughput sequencing of the antibody repertoire
Georgiou, G., Ippolito, G. C., Beausang, J., Busse, C. E., Wardemann, H., & Quake, S. R. (2014) · Nature Biotechnology · doi:10.1038/nbt.2782 · Cited by 652
Metadata
- Authors
- Burton, D. R., Ahmed, R., Barouch, D. H., Butera, S. T., Crotty, S., Godzik, A., Kaufmann, D. E., McElrath, M. J., Nussenzweig, M. C., Pulendran, B., Scanlan, C. N., Schief, W. R., Silvestri, G., Streeck, H., Walker, B. D., Walker, L. M., Ward, A. B., Wilson, I. A., & Wyatt, R.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 12
- Issue
- 4
- Pages
- 396-407
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W1972341594
- Cited by
- 375
- References
- 135
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.